My research shows that this drug is best in the area for its purpose...should be number 1 within a year.The scientific data is very plain.
Jedi you need more tutelage by the lipid masters before spouting such nonsense, you need to return to Dagobah as clearly you know not of what you speak.
I believe you are wrong. Better drugs will be approved this year 1. company is NEPT. 2. Omthera.
This is why the drop. Soon there will be to many choices with AMRN receiving the short end.